Wound Care Biologics Market: Industry Growth, Size, Share and Forecast 2019-2025

The global wound care biologics market is estimated to grow at a CAGR of 8.2% during the forecast period. The increasing number of cases of chronic wounds such as ulcers are influencing the global wound care biologics market growth. Factors attributing to the growing prevalence of ulcers include an aging population. US Census Bureau estimated that people aged over 65 years represented around 15% of the total population of the country in 2014. This share is further estimated to reach 21% by 2030 and 24% by 2060. Furthermore, as per the Agency for Healthcare Quality and Research, pressure ulcers (PU) affects around 2.5 million patients annually, which results in related costs range from $9.1 billion to $11.6 billion per year in the US.

To know more information, please request a free report sample https://www.omrglobal.com/request-sample/wound-care-biologics-market

Though PU is largely preventable, however, it results in 60,000 mortalities annually in the country. Wound care biologics solutions are largely used by patients to prevent or reduce the effect of PU. As per the National Pressure Ulcer Advisory Panel (NPUAP) in 2016, the prevalence of leg ulceration is about 1% to 2% higher in the elder population. The most common type of leg ulcers is venous ulcers, that are accounting for almost 80% of all lower extremely ulcerations. Therefore, the high prevalence of PU and venous ulcers across the globe significantly drive the demand for wound care biologics products over the forecast period.

A full report of Wound Care Biologics Market is available at: https://www.omrglobal.com/industry-reports/wound-care-biologics-market

Moreover, about one-third of the patient with chronic venous insufficiency develops venous ulceration before the age of 40 years. Additionally, the venous ulcers are associated with a high rate of recurrence and may have prolonged duration, which causes the prevalence of ulcers. Diabetic ulcers are the most common cause of leg ulcers. Many of these ulcers are a direct result of the loss of sensation secondary to peripheral neuropathy.
According to NPUAP, about 15% of people with diabetes develop foot ulceration during their lifetime. One of the major difficulties of diabetes mellitus in the development of diabetic foot ulcers (DFU). Besides PU, venous ulcers, and diabetic ulcers, an increasing number of burning cases across the globe is also leading to the expansion of wound care biologics market size across the globe.

Current Market Trends Covered in the Global Wound Care Biologics Market Report

• On the basis of the wound type segment, the ulcers segment is estimated to hold the maximum market share over the forecast period.
• Asia-Pacific is estimated to gain maximum traction in the global wound care biologics industry during the forecast period.
• Based on the end-use segment, hospitals and clinics are estimated to hold the largest market share over the forecast period.

Global Wound Care Biologics Market Segmentation

By Product

• Skin Substitute
• Topical Agent

By Wound Type

• Ulcers
• Surgical and Traumatic Wounds
• Burns
• By End-Use

Hospitals and Clinics

• Burn Center
• Homecare

Global Wound Care Biologics Market – Segment by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa

Company Profiles

• 3M Co.
• ACell Inc.
• Anika Therapeutics Inc.
• Applied Biologics LLC
• Integra LifeSciences Holdings Corp.
• Johnson & Johnson Services, Inc.
• Kerecis
• Marine Polymer Technologies, Inc.
• MiMedx Group, Inc.
• Mölnlycke Health Care AB
• Organogenesis Inc.
• Smith & Nephew PLC
• Solsys Medical LLC
• Vericel Corp.
• Wright Medical Group NV

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.